American Journal of Respiratory Medicine

Adverse Effects of -Agonists: Are They Clinically Relevant?
pp. 287-297(11)
Authors: Abramson M.J.; Walters J.; Walters E.H.

Pharmacotherapy of the Ion Transport Defect in Cystic Fibrosis: Role of Purinergic Receptor Agonists and Other Potential Therapeutics
pp. 299-309(11)
Authors: Kunzelmann K.; Mall M.

Pharmacotherapeutic Management of Pulmonary Sarcoidosis
pp. 311-320(10)
Author: Fazzi P.

Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
pp. 321-332(12)
Authors: Conway S.P.; Brownlee K.G.; Denton M.; Peckham D.G.

The Dilemma of Occupational Rhinitis: Management Options
pp. 333-341(9)
Authors: Hellgren J.; Karlsson G.; Torén K.

BiPAP Ventilation as Assistance for Patients Presenting with Respiratory Distress in the Department of Emergency Medicine
pp. 343-347(5)
Authors: Yosefy C.; Hay E.; Ben-Barak A.; Derazon H.; Magen E.; Reisin L.; Scharf S.

Clinical Efficacy of Inhaler Devices Containing 2-Agonist Bronchodilators in the Treatment of Asthma: Cochrane Systematic Review and Meta-Analysis of More Than 100 Randomized, Controlled Trials
pp. 349-365(17)
Author: Ram F.S.F.